Abstract
Pancreas transplantation is the only treatment of Type I diabetes that consistently establishes an insulin-independent, normoglycemic state. Currently long-term insulin-independence is achieved in > 80% of recipients of pancreas grafts placed simultaneous with the kidney and in > 70% of recipients of a pancreas after a kidney and non-uremic recipients of a pancreas alone. The penalty is immunosuppression, already obligatory for a kidney recipient, but the benefits are improved quality of life and the effect that perfect control of glycemia can have on secondary complications of diabetes.
Key Words:
Additional information
Notes on contributors
J. Pirenne
J. Pirenne Md, PhD Abdominal Transplant Surgery Department U.Z. Leuven Herestraat 49 B-3000 Leuven Tel.: (016)34 87 27 Fax: (016)34 87 43 E-mail: [email protected]